Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
Here's a roundup of top developments in the biotech space over the last 24 hours:
22nd Century Announces $35M Registered Direct Offering Priced $2.05/Share
2nd Century Group, Inc. (NASDAQ:XXII), leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today
Why Carnival Stock Is Sinking Today
Carnival Corp (NYSE: CCL) shares are trading lower Thursday after the company announced a $1 billion common stock offering. The offering of 102,139,621 shares of common stock was priced at $9.95 per share.
Verve Therapeutics Priced Upsized Public Offering of ~8.33M Shares Common Stock @$27/Share
Verve Therapeutics, Inc.
After-Hours Alert: Why Carnival Shares Are Sinking
Carnival Corp (NYSE: CCL) shares are trading lower in Wednesday's after-hours session after the company announced a $1 billion common stock offering.
Carnival Corporation Announces $1B Offering
Carnival Corporation & plc Announces Offering of Common Stock
MIAMI, July 20, 2022 /PRNewswire/ -- Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK), today announced that Carnival Corporation (the